Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences Signs Deal to Join MedBiomix Network

NEW YORK (GenomeWeb) – MedBiomix today announced a collaboration with Proteome Sciences to provide clinicians with expertise on how to utilize protein expression data to help improve patient care.

Cobham, UK-based Proteome Sciences joins MedBiomix's network of firms seeking to advance data-driven patient care. The global network includes medical centers of excellence, molecular diagnostic and genomics professionals, and representatives from the diagnostics and pharmaceutical industries, MedBiomix said in a statement.

Proteome Science's "knowledge in measurement of protein expression and post-translational modifications will bring an additional, very important dimension to our set of expertise beyond DNA and RNA analysis," Patrice Denèfle, co-founder of MedBiomix Partners, said in a statement.

Proteome Sciences also provides biomarker discovery and validation, and assay development services.

Financial and other details of the agreement were not disclosed. 

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.